State of Michigan Retirement System’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-4,510
Closed -$204K – 976
2022
Q2
$204K Buy
+4,510
New +$234K ﹤0.01% 969
2021
Q2
– Sell
-3,762
Closed -$681K – 984
2021
Q1
$681K Buy
+3,762
New +$650K ﹤0.01% 957
2020
Q4
– Sell
-4,358
Closed -$543K – 976
2020
Q3
$543K Buy
+4,358
New +$457K ﹤0.01% 912
2020
Q2
– Sell
-4,570
Closed -$285K – 957
2020
Q1
$285K Buy
+4,570
New +$357K ﹤0.01% 901

Other funds holding TXG

State of Michigan Retirement System's TXG Position: Q3 2022 in Review

State of Michigan Retirement System sold out of 10x Genomics (TXG) in Q3 2022, closing a stake of 4,510 shares — an estimated $204K sold.

State of Michigan Retirement System first reported a position in TXG in Q1 2020 and held it in 4 quarters. The position peaked at $681K in Q1 2021. 233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

  • State of Michigan Retirement System reported no remaining 10x Genomics position as of Q3 2022 after selling out during the quarter.
  • State of Michigan Retirement System sold 4,510 10x Genomics shares in Q3 2022, an estimated $204K.
  • State of Michigan Retirement System first reported a position in 10x Genomics in Q1 2020 and held it in 4 quarters.
  • State of Michigan Retirement System's 10x Genomics position peaked at $681K in Q1 2021.
  • 233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on State of Michigan Retirement System's 13F filing for Q3 2022, filed 24 Oct 2022.